306 related articles for article (PubMed ID: 25865359)
1. Inhibitors of the apurinic/apyrimidinic endonuclease 1 (APE1)/nucleophosmin (NPM1) interaction that display anti-tumor properties.
Poletto M; Malfatti MC; Dorjsuren D; Scognamiglio PL; Marasco D; Vascotto C; Jadhav A; Maloney DJ; Wilson DM; Simeonov A; Tell G
Mol Carcinog; 2016 May; 55(5):688-704. PubMed ID: 25865359
[TBL] [Abstract][Full Text] [Related]
2. APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC.
Malfatti MC; Gerratana L; Dalla E; Isola M; Damante G; Di Loreto C; Puglisi F; Tell G
J Exp Clin Cancer Res; 2019 Jul; 38(1):309. PubMed ID: 31307523
[TBL] [Abstract][Full Text] [Related]
3. Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology.
Vascotto C; Lirussi L; Poletto M; Tiribelli M; Damiani D; Fabbro D; Damante G; Demple B; Colombo E; Tell G
Oncogene; 2014 May; 33(22):2876-87. PubMed ID: 23831574
[TBL] [Abstract][Full Text] [Related]
4. Nucleophosmin interaction with APE1: Insights into DNA repair regulation.
López DJ; de Blas A; Hurtado M; García-Alija M; Mentxaka J; de la Arada I; Urbaneja MA; Alonso-Mariño M; Bañuelos S
DNA Repair (Amst); 2020 Apr; 88():102809. PubMed ID: 32092641
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic significance of APE1/Ref-1 and NPM1 proteins in high-grade ovarian serous cancer.
Londero AP; Orsaria M; Tell G; Marzinotto S; Capodicasa V; Poletto M; Vascotto C; Sacco C; Mariuzzi L
Am J Clin Pathol; 2014 Mar; 141(3):404-14. PubMed ID: 24515769
[TBL] [Abstract][Full Text] [Related]
6. APE1/Ref-1 interacts with NPM1 within nucleoli and plays a role in the rRNA quality control process.
Vascotto C; Fantini D; Romanello M; Cesaratto L; Deganuto M; Leonardi A; Radicella JP; Kelley MR; D'Ambrosio C; Scaloni A; Quadrifoglio F; Tell G
Mol Cell Biol; 2009 Apr; 29(7):1834-54. PubMed ID: 19188445
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).
Laev SS; Salakhutdinov NF; Lavrik OI
Bioorg Med Chem; 2017 May; 25(9):2531-2544. PubMed ID: 28161249
[TBL] [Abstract][Full Text] [Related]
8. Diverse small molecule inhibitors of human apurinic/apyrimidinic endonuclease APE1 identified from a screen of a large public collection.
Dorjsuren D; Kim D; Vyjayanti VN; Maloney DJ; Jadhav A; Wilson DM; Simeonov A
PLoS One; 2012; 7(10):e47974. PubMed ID: 23110144
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of APE1-endonuclease activity affects cell metabolism in colon cancer cells via a p53-dependent pathway.
Codrich M; Comelli M; Malfatti MC; Mio C; Ayyildiz D; Zhang C; Kelley MR; Terrosu G; Pucillo CEM; Tell G
DNA Repair (Amst); 2019 Oct; 82():102675. PubMed ID: 31450087
[TBL] [Abstract][Full Text] [Related]
10. Receptor-based virtual screening and biological characterization of human apurinic/apyrimidinic endonuclease (Ape1) inhibitors.
Ruiz FM; Francis SM; Tintoré M; Ferreira R; Gil-Redondo R; Morreale A; Ortiz ÁR; Eritja R; Fàbrega C
ChemMedChem; 2012 Dec; 7(12):2168-78. PubMed ID: 23109358
[TBL] [Abstract][Full Text] [Related]
11. Nucleophosmin modulates stability, activity, and nucleolar accumulation of base excision repair proteins.
Poletto M; Lirussi L; Wilson DM; Tell G
Mol Biol Cell; 2014 May; 25(10):1641-52. PubMed ID: 24648491
[TBL] [Abstract][Full Text] [Related]
12. Novel small-molecule inhibitor of apurinic/apyrimidinic endonuclease 1 blocks proliferation and reduces viability of glioblastoma cells.
Bapat A; Glass LS; Luo M; Fishel ML; Long EC; Georgiadis MM; Kelley MR
J Pharmacol Exp Ther; 2010 Sep; 334(3):988-98. PubMed ID: 20504914
[TBL] [Abstract][Full Text] [Related]
13. The expression profile and prognostic value of APE/Ref-1 and NPM1 in high-grade serous ovarian adenocarcinoma.
Fan X; Wen L; Li Y; Lou L; Liu W; Zhang J
APMIS; 2017 Oct; 125(10):857-862. PubMed ID: 28766835
[TBL] [Abstract][Full Text] [Related]
14. Elevated level of acetylation of APE1 in tumor cells modulates DNA damage repair.
Sengupta S; Mantha AK; Song H; Roychoudhury S; Nath S; Ray S; Bhakat KK
Oncotarget; 2016 Nov; 7(46):75197-75209. PubMed ID: 27655688
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Macrocyclic Inhibitors of Apurinic/Apyrimidinic Endonuclease 1.
Trilles R; Beglov D; Chen Q; He H; Wireman R; Reed A; Chennamadhavuni S; Panek JS; Brown LE; Vajda S; Porco JA; Kelley MR; Georgiadis MM
J Med Chem; 2019 Feb; 62(4):1971-1988. PubMed ID: 30653918
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone.
Luo M; Kelley MR
Anticancer Res; 2004; 24(4):2127-34. PubMed ID: 15330152
[TBL] [Abstract][Full Text] [Related]
17. Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition.
Wang D; Luo M; Kelley MR
Mol Cancer Ther; 2004 Jun; 3(6):679-86. PubMed ID: 15210853
[TBL] [Abstract][Full Text] [Related]
18. Conformational Rearrangements Regulating the DNA Repair Protein APE1.
Komaniecka N; Porras M; Cairn L; Santas JA; Ferreiro N; Penedo JC; Bañuelos S
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887361
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of 3-carbamoylbenzoic acid derivatives as inhibitors of human apurinic/apyrimidinic endonuclease 1 (APE1).
Aiello F; Shabaik Y; Esqueda A; Sanchez TW; Grande F; Garofalo A; Neamati N
ChemMedChem; 2012 Oct; 7(10):1825-39. PubMed ID: 22952012
[TBL] [Abstract][Full Text] [Related]
20. Pharmacophore guided discovery of small-molecule human apurinic/apyrimidinic endonuclease 1 inhibitors.
Zawahir Z; Dayam R; Deng J; Pereira C; Neamati N
J Med Chem; 2009 Jan; 52(1):20-32. PubMed ID: 19072053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]